Recent advances in cryoballoon ablation for atrial fibrillation

Expert Rev Med Devices. 2019 Sep;16(9):799-808. doi: 10.1080/17434440.2019.1653181. Epub 2019 Aug 16.

Abstract

Introduction: Pulmonary vein isolation (PVI), by catheter ablation, represents the current treatment for drug-resistant atrial fibrillation (AF). Nowadays cryoballoon (CB) is a recognized ablation method in patients with atrial fibrillation, mainly due to its ease of use, leading to reproducible and fast procedures. This novel single shot technology literally revolutionized the approach to AF ablation. Areas covered: The historical development of the cryoballoon, ablation techniques and new approaches beyond the ordinary PVI and complications are summarized here. Expert opinion: Although cryoballoon ablation has greatly standardized the approach to PVI a few critical points still need to be clarified scientifically in order to further uniform this procedure in cath labs worldwide. Duration and dosage of the cryoapplication is undoubtedly a topic of great interest.

Keywords: Appendage isolation; atrial fibrillation; autonomic nervous system; catheter ablation; cryoablation; cryoballoon; ganglionated plexi; left atrial posterior wall isolation pulmonary vein isolation.

Publication types

  • Review

MeSH terms

  • Atrial Fibrillation / surgery*
  • Biophysical Phenomena
  • Catheter Ablation* / adverse effects
  • Cryosurgery* / adverse effects
  • Humans
  • Treatment Outcome